Abstract | OBJECTIVE: To investigate the clinical effects of Qianlieping Capsule combined with alpha-receptor blocker tamsulosin on chronic non-bacterial prostatitis (CNBP). METHODS: We assigned 220 CNBP patients to three groups to receive oral Qianlieping Capsule (2.0 g tid) plus alpha-receptor blocker tamsulosin (0.2 mg qd) (n = 98), Qianlieping Capsule alone at 2.0 g tid (n = 66), and tamsulosin alone at 0.2 mg qd (n = 56) , respectively. After 6 weeks of medication, we assessed the therapeutic effects according to the NIH-CPSI scores and the number of small particles of lecithin (SPL) in the prostatic fluid after treatment. RESULTS: Qianlieping Capsule alone increased the number of SPL by 46.9% and reduced the NIH-CPSI score by 24.4%. Combination of Qianlieping and tamsulosin more significantly increased the number of SPL (61.4%) and decreased the NIH-CPSI score (42.3%) than tamsulosin alone (33.7% and 28.6%) (P < 0.01). CONCLUSION:
|
Authors | Jian-Ping Li, Tie Chong, Hai-Wen Chen, He-Cheng Li, Jun Cao, Peng Zhang, Hong-Liang Li |
Journal | Zhonghua nan ke xue = National journal of andrology
(Zhonghua Nan Ke Xue)
Vol. 18
Issue 9
Pg. 856-8
(Sep 2012)
ISSN: 1009-3591 [Print] China |
PMID | 23193678
(Publication Type: Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Adrenergic alpha-Antagonists
- Capsules
- Drugs, Chinese Herbal
- Sulfonamides
- Tamsulosin
|
Topics |
- Adolescent
- Adrenergic alpha-Antagonists
(administration & dosage, therapeutic use)
- Adult
- Capsules
- Chronic Disease
- Drugs, Chinese Herbal
(administration & dosage, therapeutic use)
- Humans
- Male
- Phytotherapy
- Prostatitis
(drug therapy)
- Sulfonamides
(administration & dosage, therapeutic use)
- Tamsulosin
- Treatment Outcome
- Young Adult
|